Cargando…

Accelerated FEV(1) decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients

Accelerated lung function decline has been associated with increased risk of cardiovascular disease (CVD) in a general population, but little is known about this association in chronic obstructive pulmonary disease (COPD). We investigated the association between accelerated lung function decline and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whittaker, Hannah R., Bloom, Chloe, Morgan, Ann, Jarvis, Deborah, Kiddle, Steven J., Quint, Jennifer K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930472/ https://www.ncbi.nlm.nih.gov/pubmed/32972984 http://dx.doi.org/10.1183/13993003.00918-2020

Ejemplares similares

Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population
por: Whittaker, Hannah R, et al.
Publicado: (2021)

Inhaled corticosteroids, blood eosinophils, and FEV(1) decline in patients with COPD in a large UK primary health care setting
por: Whittaker, Hannah R, et al.
Publicado: (2019)

Inhaled corticosteroids and FEV(1) decline in chronic obstructive pulmonary disease: a systematic review
por: Whittaker, Hannah R., et al.
Publicado: (2019)

Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease
por: Whittaker, Hannah R, et al.
Publicado: (2020)

Prediction of five-year mortality after COPD diagnosis using primary care records
por: Kiddle, Steven J., et al.
Publicado: (2020)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

Obstructive sleep apnoea accelerates FEV(1) decline in asthmatic patients
por: Wang, Tsai-Yu, et al.
Publicado: (2017)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD
por: Rosso, Aldana, et al.
Publicado: (2022)

FEV(1) is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease
por: Bikov, Andras, et al.
Publicado: (2020)

Rate of Decline of FEV(1) as a Biomarker of Survival?
por: Papi, Alberto, et al.
Publicado: (2021)

Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1)
por: Lange, Peter, et al.
Publicado: (2016)

Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV(1) decline: results from COPDGene and SPIROMICS
por: Wang, Jennifer M., et al.
Publicado: (2023)

Predictors of accelerated FEV(1) decline in adults with airflow limitation—Findings from the Health2006 cohort
por: Baarnes, Camilla Boslev, et al.
Publicado: (2019)

COPD assessment test and FEV(1): do they predict oxygen uptake in COPD?
por: Carvalho-Jr, Luiz Carlos S, et al.
Publicado: (2018)

COPD-associated miR-145-5p is downregulated in early-decline FEV(1) trajectories in childhood asthma
por: Tiwari, Anshul, et al.
Publicado: (2020)

A novel CT-emphysema index/FEV(1) approach of phenotyping COPD to predict mortality
por: Loh, Li-Cher, et al.
Publicado: (2018)

The Relationship between COPD and Cardiovascular Disease
por: Quint, Jennifer
Publicado: (2017)

Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV(1) for COPD in Chinese Population: A Prospective Cohort Study
por: Wang, Yunxia, et al.
Publicado: (2019)

Rapid FEV(1)/FVC Decline Is Related With Incidence of Obstructive Lung Disease and Mortality in General Population
por: Choi, Kwang Yong, et al.
Publicado: (2022)

Hospitalisation and mortality outcomes of patients with comorbid COPD and heart failure: a systematic review protocol
por: Axson, Eleanor L, et al.
Publicado: (2018)

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)

Inflammatory and immunological profiles in patients with COPD: relationship with FEV (1) reversibility
por: Queiroz, Cleriston Farias, et al.
Publicado: (2016)

Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients
por: Mokari-Yamchi, Amin, et al.
Publicado: (2019)

Pulmonary function testing in COPD: looking beyond the curtain of FEV1
por: Kakavas, Sotirios, et al.
Publicado: (2021)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis
por: Axson, Eleanor L., et al.
Publicado: (2020)

Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016
por: Bloom, Chloe I, et al.
Publicado: (2019)

Low uptake of palliative care for COPD patients within primary care in the UK
por: Bloom, Chloe I., et al.
Publicado: (2018)

Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns
por: Aghili, Rokhsareh, et al.
Publicado: (2013)

Systematic review of the evidence relating FEV(1 )decline to giving up smoking
por: Lee, Peter N, et al.
Publicado: (2010)

Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement
por: Jones, Paul, et al.
Publicado: (2012)

Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
por: Bloom, Chloe I, et al.
Publicado: (2020)

Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care
por: Bloom, C. I., et al.
Publicado: (2019)

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
por: Whittaker, Hannah, et al.
Publicado: (2022)

Reliability of FEV(1)/FEV(6) to Diagnose Airflow Obstruction Compared with FEV(1)/FVC: The PLATINO Longitudinal Study
por: Perez-Padilla, Rogelio, et al.
Publicado: (2013)

Decline in FEV(1) and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
por: Hiller, Adriana-Maria, et al.
Publicado: (2019)

Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART
por: Samperiz, Gloria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3efqhn9lqjd7k0ji2kdia3o1sh